Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of HZ-A-018 in adults with chronic or persistent primary immune thrombocytopenia
CTR20254210Phase 2Active
- Sponsor
- Hezheng Pharma
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HZ-A-018 in immune thrombocytopenia (ITP), sponsored by Hezheng Pharma. Started Oct 2025; status: active.
02
Drugs
HZ-A-018
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on CTR20254210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254210.